Buy Target $13.97 or better Sell Target – TradersPro Sell Signal Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. The company primarily serves hospitals and […]
Read MoreBuy Target – $3.74 Sell Target – $5.23 Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company focusing on the development of antibody drug conjugate (ADC) for cancer patients with unmet need. The company develops Dolaflexin, a platform, which is used to generate a pipeline of proprietary ADC product candidates to address patient populations that are […]
Read MorePlus, the impeachment inquiry is moving on to the Judiciary Committee, the FAA is tightening its grip on Boeing, and Deere shares are sliding.
Read MorePlus, there’s a new probe into Goldman Sachs’ credit card practices after some complaints related to its Apple Card, Alibaba is on track to deliver record sales for its biggest shopping event of the year, and Boeing is planning to resume shipments of its 737 Max plane in December.
Read MorePlus, the U.S. and China are close to finalizing parts of the phase one trade deal, Intel delivered an earnings beat, and PG&E shares are in free-fall.
Read MoreTrade Setup Buy Target – $12.30 or better Sell Target – TradersPro Sell Signal Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. The company primarily […]
Read MoreAnalysts are bullish on these 5 stocks. Here’s why.
Read MorePlus, the White House isn’t planning on blocking Chinese investments at this point, Forever 21 is filing for bankruptcy, and WeWork is formally requesting to postpone its IPO.
Read MorePlus, the whistleblower’s complaint has been released, Peloton has gone public, and McDonald’s is about to test out plant-based burgers.
Read MoreTrade Setup Buy Target – $8.70 or better Sell Target – TradersPro Sell Signal CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and other diseases. The company’s lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of primary head and neck cancer. […]
Read More